Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Handelnine Global, LLC dba Navafresh
WARNING LETTER
•Handelnine Global, LLC dba Navafresh•September 30, 2025

Handelnine Global, LLC dba Navafresh – FDA Warning Letter, Sep 30, 2025

Record Details

The U.S. Food and Drug Administration (FDA) issued a Warning Letter to Handelnine Global, LLC, operating as Navafresh, on November 17, 2025. This action followed a September 2025 review of the company"s website and the sampling of its "Rheumacare Capsules" product. The FDA determined that Navafresh is illegally selling several products in the U.S., including "Dr. Patels Measles Tablets," "Mans-Pachak Vati," and "Tri-Origin Ayurveda Diabetic Tablets," which are considered unapproved new drugs under section 505(a) of the Federal Food, Drug, and Cosmetic Act (FD&C Act).

Additionally, "Rheumacare Capsules" was found to be a misbranded drug under section 502 of the FD&C Act. Laboratory testing of "Rheumacare Capsules" revealed the presence of lead, rendering it an adulterated drug under section 501(a)(2)(B) due to safety concerns and non-compliance with current Good Manufacturing Practice (CGMP) requirements. The FDA highlighted significant public health risks, particularly from products claiming to treat serious conditions like cancer, diabetes, and measles, potentially leading consumers to delay or forgo effective medical care. Ophthalmic products were also noted as posing increased harm. Navafresh must cease marketing these unapproved, misbranded, and adulterated products to comply with federal law.

Company
Handelnine Global, LLC dba Navafresh
Inspection date
September 30, 2025
Product type
Drugs
Office
Center for Drug Evaluation and Research
People
  • Tina Smith (Director)
  • Francis Godwin (Director)
View Company Profile

ID · 2aaaf9f2-f6f9-438e-aed4-c7b55ff659ba

Violation Codes10
21 U.S.C. 351(a)(2)(B)FD&C Act 505(a)21.U.S.C. 355(a)FD&C Act 301(d)21 U.S.C. 331(d)FD&C Act 50221 U.S.C. 352FD&C Act 301(a)21.U.S.C. 331(a)FD&C Act 501(a)(2)(B)

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Handelnine Global, LLC dba Navafresh
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.